Each year, cervical cancer claims hundreds of thousands of lives — a burden borne most heavily by women in places where medicine's reach is shortest. In a laboratory, researchers have now coaxed tiny silica particles into something resembling precision: a nanocarrier that seeks out cancer cells by exploiting their hunger for folic acid, delivering a lethal payload while leaving healthy tissue largely undisturbed. The work is early, confined to cell cultures rather than human bodies, yet it gestures toward a future in which the blunt instrument of chemotherapy might be replaced by something far